Cynata Therapeutics' (ASX:CYP) clinical trials gaining pace | Kalkine Media скачать в хорошем качестве

Cynata Therapeutics' (ASX:CYP) clinical trials gaining pace | Kalkine Media

Cynata Therapeutics' (ASX:CYP) clinical trials gaining pace | Kalkine Media Australian stem cell and regenerative medicine company, Cynata Therapeutics Limited, is developing disruptive regenerative medicines. The company is focused on producing mesenchymal stem cell (MSC)-based products using its therapeutic stem cell platform technology, Cymerus™. #asx #cyp #cynatatherapeutics #cymerus #drrossmacdonald #experttalks #kalkinemedia Today, we interact with Dr. Ross Macdonald, Managing Director & CEO of Cynata, to understand how the company is picking up pace with its broad and diverse clinical trial pipeline. Explore insightful and in-depth research on select stocks by Kalkine. Subscribe to the premium services here click on https://bit.ly/3LR6bD3 To get more updates about Australia, NZ, UK, Canada and US stock market news, investors education & insights, subscribe our channel at https://bit.ly/3cHKioy Check out our media Website 👉 https://kalkinemedia.com/au Follow us and stay updated on the Go with the Market Charter 👇👇 Facebook -   / kalkineau   Twitter -   / kalkineau   LinkedIn -   / 4829818   #stemcell #australia #kalkinemedia